体重指数对假体乳房重建术后并发症风险影响有限:1847例回顾性队列研究
该回顾性队列研究纳入2010—2023年三个整形外科连续接受假体乳房重建的1847例患者(2631侧乳房),以体重指数(BMI)为连续变量分析并发症风险。结果显示,在即刻重建患者中BMI与假体丢失风险显著相关(P=0.04),延迟重建中无显著相关(P=0.22);BMI升高与假体感染(P=0.003)和血清肿(P<0.001)显著相关。作者认为BMI≤30 kg/m²的患者不应被劝阻接受假体乳房重建,但较高BMI患者延迟重建可能是更安全的选择。
要点
- 即刻重建中BMI与假体丢失风险显著相关(P=0.04),延迟重建中无显著相关(P=0.22)。
- BMI升高与假体感染(P=0.003)和血清肿(P<0.001)显著相关,与血肿或皮瓣坏死无显著相关。
- BMI 23与30 kg/m²之间即刻重建假体丢失绝对风险差为2.0%(95%CI -2.9至6.8)。
核心结论
- BMI 23至30 kg/m²之间并发症绝对风险差异较小,BMI≤30 kg/m²的患者不应被劝阻接受假体乳房重建。
- 作者认为,对于较高BMI患者,延迟重建可能是更安全的选择。
研究设计与样本
- 回顾性队列研究,纳入2010—2023年三个整形外科连续接受假体乳房重建的患者1847例(2631侧乳房)。
- 以BMI为连续变量,主要结局为按即刻与延迟重建分层的假体丢失,次要结局包括假体感染、血清肿、血肿和乳房切除皮瓣坏死,均采用多变量Cox回归分析。
主要发现
- 中位BMI为23.3 kg/m²(IQR 21.0-25.8,范围17.1-36.9)。
- 即刻重建患者中BMI与假体丢失风险显著相关(P=0.04),延迟重建患者中无显著相关(P=0.22)。
- 总体BMI升高与假体感染风险显著相关(P=0.003)和血清肿风险显著相关(P<0.001),与血肿或乳房切除皮瓣坏死无显著相关。
- 即刻重建中BMI 23 kg/m²(6.2%)与30 kg/m²(8.2%)之间假体丢失绝对风险差为2.0%(95%CI -2.9至6.8)。
关键数值与推荐
- 即刻重建中BMI 23 kg/m²假体丢失绝对风险为6.2%,BMI 30 kg/m²为8.2%,绝对风险差2.0%(95%CI -2.9至6.8)。
- 即刻重建中BMI与假体丢失显著相关(P=0.04),延迟重建中无显著相关(P=0.22)。
- BMI与假体感染显著相关(P=0.003),与血清肿显著相关(P<0.001)。
临床怎么用
- 作者认为,BMI≤30 kg/m²的患者不应被劝阻接受假体乳房重建。
- 作者认为,较高BMI患者延迟重建可能是更安全的选择。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: High body mass index (BMI) has been linked to higher risk of complications following implant-based breast reconstruction. However, the impact of increasing BMI within the normal to overweight range (18.5-30 kg/m2) remains underexplored. We aimed to examine the association between BMI and complications and evaluate differences in risk of implant loss between patients undergoing immediate- and delayed reconstruction. METHODS: Consecutive patients who underwent implant-based breast reconstruction from 2010-2023 at three plastic surgical departments were analyzed with BMI as a continuous variable. The primary outcome was implant loss stratified by immediate versus delayed reconstruction. Secondary outcomes included implant infection, seroma, hematoma, and mastectomy skin flap necrosis. All outcomes were analyzed with multivariate Cox regression. RESULTS: We included 1847 patients (2631 breasts) with a median BMI of 23.3 kg/m2 (IQR 21.0-25.8, range 17.1-36.9). In patients undergoing immediate reconstruction, BMI was significantly associated with an increased risk of implant loss (P=0.04) but not after delayed reconstruction (P=0.22). Overall, higher BMI was significantly associated with risk of implant infection (P=0.003) and seroma (P<0.001) but not hematoma or mastectomy skin flap necrosis. The absolute risk difference for implant loss between BMI 23 kg/m² (6.2%) and 30 kg/m² (8.2%) was 2.0% (95% CI -2.9 to 6.8) for immediate reconstruction. CONCLUSION: The small absolute risk differences for complications in patients with BMI between 23 and 30 kg/m² suggest that patients with BMI ≤30 kg/m² should not be discouraged from implant-based breast reconstruction. However, delayed reconstruction may be a safer option for patients with higher BMI.
引用
- Weltz TK, Skautrup SM, Snog MO, et al. Limited impact of body mass index on the risk of postoperative complications after implant-based breast reconstruction: A retrospective cohort study of 1847 patients. J Plast Reconstr Aesthet Surg. 2025. PMID: 40174261. doi:10.1016/j.bjps.2025.02.046
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。